Medical Cannabis

Lipid-based drug delivery of medical cannabis actives, such as CBD and THC, can provide numerous advantages, including improved solubility, increased bioavailability, transdermal transport, expanded routes of administration, faster onset of action and reduced gastric degradation of cannabis actives.

Multiple Dosage Form Options

Cannabis actives can be dissolved in single or multiple lipid pre-concentrates composed of ABITEC functional lipids to be employed in the development of a variety of dosage forms, including:

• Per-oral capsules and tablets
• Creams and gels
• Lipid nanoparticles
• Nasal sprays and inhalers
• Oral solutions

All information and statements given in this brochure are believed to be accurate at the time of publication. However, neither ABITEC Corporation nor any of their affiliates make any representations or warranty with respect thereto, including, but not limited to, any results obtained in the processing of the products by customers or any third party. All information and statements are intended for persons having the required skill and know-how and do not relieve the customer or user from verifying the suitability of information and statements given for a specific purpose prior to use of the products. It is entirely the obligation of the customer or user to comply with applicable laws and regulations, and also with all patent or other intellectual property rights of third parties. ABITEC CORPORATION EXPRESSELY DISCLAIMS ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND, WHETHER EXPRESSED OR IMPLIED, AS TO THE ACCURACY, CURRENCY, COMPLETENESS AND/OR THE MERCHANTABILITY OR FITNESS OF A PARTICULAR PURPOSE OF ANY INFORMATION CONTAINED IN THIS BROCHURE AND/OR PRODUCT DESCRIBED OR PROMOTED IN THIS BROCHURE, INCLUDING WARRATNTIES WITH RESPECT TO INFRINGEMENT OF ANY PATENT, COPYRIGHT, OR OTHER RIGHTS OF A THIRD PARTY. We reserve the right to change product specification and it specified properties of the products without prior notice.